FLUARIX TETRA inactivated split influenza vaccine suspension for injection 0.5 mL pre-filled PRTC syringe without needle, SH2024 influenza season Австралія - англійська - Department of Health (Therapeutic Goods Administration)

fluarix tetra inactivated split influenza vaccine suspension for injection 0.5 ml pre-filled prtc syringe without needle, sh2024 influenza season

glaxosmithkline australia pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: dl-alpha-tocopheryl acid succinate; potassium chloride; sodium chloride; water for injections; polysorbate 80; dibasic sodium phosphate dodecahydrate; magnesium chloride hexahydrate; octoxinol 10; monobasic potassium phosphate - fluarix tetra is a quadrivalent vaccine indicated for active immunisation of adults and children from 6 months of age for the prevention of influenza disease caused by the influenza virus types a and b contained in the vaccine (see section 5.1 pharmacodynamic properties, clinical trials).,the use of fluarix tetra should be based on official recommendations.

FLUARIX TETRA inactivated split influenza vaccine suspension for injection 0.5 mL pre-filled syringe without needle, SH2024 influenza season Австралія - англійська - Department of Health (Therapeutic Goods Administration)

fluarix tetra inactivated split influenza vaccine suspension for injection 0.5 ml pre-filled syringe without needle, sh2024 influenza season

glaxosmithkline australia pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: dl-alpha-tocopheryl acid succinate; potassium chloride; sodium chloride; water for injections; polysorbate 80; dibasic sodium phosphate dodecahydrate; magnesium chloride hexahydrate; octoxinol 10; monobasic potassium phosphate - fluarix tetra is a quadrivalent vaccine indicated for active immunisation of adults and children from 6 months of age for the prevention of influenza disease caused by the influenza virus types a and b contained in the vaccine (see section 5.1 pharmacodynamic properties, clinical trials).,the use of fluarix tetra should be based on official recommendations.

HLAL RDNA CONSTRUCT IN SBC LAL-C CHICKENS- hlal rdna construct in sbc lal-c chicken not applicable США - англійська - NLM (National Library of Medicine)

hlal rdna construct in sbc lal-c chickens- hlal rdna construct in sbc lal-c chicken not applicable

alexion pharmaceuticals, inc. - hlal rdna construct in sbc lal-c chicken (unii: mg6au4c2hb) (hlal rdna construct in sbc lal-c chicken - unii:mg6au4c2hb) - hlal rdna construct in sbc lal-c chicken 1 [arb'u] in 1 [arb'u] - the sbc lal-c lineage must be housed in only those alexion pharmaceutical, inc. facilities specified in the approved application.

HYDROCORTISONE tablet США - англійська - NLM (National Library of Medicine)

hydrocortisone tablet

avera mckennan hospital - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone 10 mg

INFLUVAC TETRA influenza virus haemagglutinin 0.5mL vaccine prefilled syringe with 16 mm needle, 2024 Австралія - англійська - Department of Health (Therapeutic Goods Administration)

influvac tetra influenza virus haemagglutinin 0.5ml vaccine prefilled syringe with 16 mm needle, 2024

viatris pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - suspension - excipient ingredients: magnesium chloride hexahydrate; monobasic potassium phosphate; dibasic sodium phosphate dihydrate; water for injections; potassium chloride; calcium chloride dihydrate; sodium chloride - for the prevention of influenza caused by influenza virus, types a and b.,for full details regarding recommendations for influenza vaccination, please refer to the relevant national immunisation guidelines.,influvac tetra is indicated in adults and children from 6 months of age and older.

GLIVEC  400 MG Ізраїль - англійська - Ministry of Health

glivec 400 mg

novartis israel ltd - imatinib as mesylate - film coated tablets - imatinib as mesylate 400 mg - imatinib - glivec is indicated for the treatment of adult patients and children 3 years of age and above with ph+ chronic myeloid leukaemia (ph+ -cml) in chronic phase accelerated phase or blast crisis. glivec is also indicated for the treatment of adult patients with kit (cd117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist). glivec is also indicated for the treament of : adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukemia (ph+ all) integrated with chemotherapy. adult patients with relapsed or refractory ph + all as monotherapy. adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. adult patients with myelodyspiastic/myeloproliferative diseases (mds/mpd) associated with pdgfr ( platelet - derived growth factor receptor ) gene re- arrangements. adult patients with hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) who have the fip1l1- pdgfralfa fusion kinase (mutational analysis or fish demonstration for chic2 allele deletion) and for patients with hes and/or cel who are fip1l1-pdgfr alfa fusion kinase negative . adult patients with aggressive systemic mastocytosis (asm) without the d816v c-kit mutation . adjuvant treatment of adult patients following complete gross resection of kit (cd117) positive gist.

Equip F Ірландія - англійська - HPRA (Health Products Regulatory Authority)

equip f

zoetis belgium s.a. - inactivated equine influenza a newmarket 77 (h7 n7) ; inactivated equine influenza a borlonge 91 (h3 n8) ; inactivated equine influenza a kentucky 98 (h3 n8) - suspension for injection - . - equine influenza virus - horses - immunological - inactivated vaccine

EQUIP F Ірландія - англійська - HPRA (Health Products Regulatory Authority)

equip f

zoetis ireland limited - influenza a/equine/1 newmarket'77, influenza a/equine/2 borlange'91, equine influenza a/equine/2kentucky 98 - suspension for injection - unknown - equine influenza virus vaccine - equine - food - immunological - inactivated vaccine

EQUIP FT Ірландія - англійська - HPRA (Health Products Regulatory Authority)

equip ft

zoetis ireland limited - influenza a/equine/1 newmarket'77, influenza a/equine/2 borlange'91, equine influenza a/equine/2kentucky 98, tetanus toxoid - suspension for injection - unknown - inactivated equine influenza virus vaccine + inactivated clostridium vaccine - equine - food - immunological - inactivated vaccine